GRAIL, Inc. (GRAL) stock analysis

In our weekly check, GRAIL, Inc. is graded D (A to F). Of 20 checks on debt, profit, cash flow and trend: 8 pass, warnings: 2, red flags: 10.

About GRAIL, Inc.

GRAIL, Inc. is a Healthcare company (Medical - Diagnostics & Research) based in the United States, listed on NASDAQ as GRAL.

What our checks show for GRAL

Red flags

Warning signs

Strengths

Similar companies

BLLN · SHC · RDNT · CDNA · QGEN · NEO

Questions

What grade does GRAIL, Inc. (GRAL) have?

In our weekly check, GRAIL, Inc. is graded D (A to F). Of 20 checks on debt, profit, cash flow and trend: 8 pass, warnings: 2, red flags: 10. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of GRAL stock?

This week's biggest flags for GRAIL, Inc.: High debt, Weak EPS forecast, Weak EPS growth. In total 12 of 20 checks show a warning or a red flag.

What does GRAIL, Inc. do?

GRAIL, Inc. is a Healthcare company (Medical - Diagnostics & Research) based in the United States, listed on NASDAQ as GRAL.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis